IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/Fine Chemicals Roundup – June 26

10:21 AM MDT | June 26, 2012 | Deepti Ramesh

HOVIONE REPORTS RISE IN SALES Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) has recorded a 24% rise in sales in the fiscal year ended March 31, 2012, compared with the previous fiscal year, to $180 million. Earnings figures were not disclosed. “During the last five years Hovione has doubled its sales and has made bold strategic steps to both strengthen its ability to serve innovators and to consolidate its leadership in off-patent contrast agents,” says Miguel Calado, chief financial officer at Hovione. “Looking...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 




Comments (1) for Pharma/Fine Chemicals Roundup – June 26
1.
<p>Other than keeping viruses at bay, <strong><a href="http://www.guidechem.com/reference/dic-420060.html">SLES</a></strong>(CAS No. 68585-34-2) is also prevalent in laxatives, medicine for heart disease and in aspirin.Modern depilatory cream usually is usually made of a mixture of strongly alkaline chemicals. Common ingredients include calcium thioglycolate and <strong><a href="http://www.guidechem.com/reference/dic-3770.html">sodium thioglycolate</a></strong>.Many patients tolerate <strong><a href="http://www.guidechem.com/reference/dic-32199.html">darunavir</a></strong> therapy very well. Common side effects include gastrointestinal upset, rash, changes in distribution of body fat, and headaches.</p>
Posted by SLES on Wednesday, July 4, 2012 @ 03:59 AM










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa